Compound 791
Identifiers
- Canonical SMILES:
Fc1cccc(c1)-n1[nH]c2ccnc(-c3cccc(c3)C(F)(F)F)c2c1=O
- InChi:
InChI=1S/C19H11F4N3O/c20-13-5-2-6-14(10-13)26-18(27)16-15(25-26)7-8-24-17(16)11-3-1-4-12(9-11)19(21,22)23/h1-10,25H
- InChiKey:
ZUICVKRDFXDHDH-UHFFFAOYSA-N
External links
168318179 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
CD80 / CD28 | 5.89 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 373.08 g/mol | |||
HBA | 4 | |||
HBD | 1 | |||
HBA + HBD | 5 | |||
AlogP | 5.32 | |||
TPSA | 45.23 | |||
RB | 3 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4742 | MK-0249 | DB11910 | |
0.4641 | ABT-288 | DB15192 | |
0.4620 | Antipyrine | DB01435 | |
0.4615 | Merestinib | DB12381 | |
0.4590 | 3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one | DB07528 | |
0.4554 | Ravoxertinib | DB15281 | |
0.4493 | Riociguat | DB08931 | |
0.4438 | 3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)-1H-INDAZOLE-6-CARBONITRILE | DB07075 | |
0.4400 | AZD-5423 | DB12280 | |
0.4386 | 3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL | DB07712 | |
0.4359 | EVT-101 | DB05956 | |
0.4345 | Methaqualone | DB04833 | |
0.4340 | Vericiguat | DB15456 | |
0.4338 | Dilmapimod | DB12140 | |
0.4326 | ATX-914 | DB12673 |